세계의 인슐린 패치 펌프 시장 : 모드, 제품, 적응 질환별 예측(2025-2030년)

The Insulin Patch Pumps Market was valued at USD 1.15 billion in 2023, expected to reach USD 1.27 billion in 2024, and is projected to grow at a CAGR of 10.65%, to USD 2.35 billion by 2030.

The insulin patch pump market is emerging as a significant segment in diabetes management, providing patients with precise and convenient insulin delivery. Insulin patch pumps are compact devices that adhere to the skin, offering a less intrusive alternative to traditional insulin delivery mechanisms such as multiple daily injections or larger insulin pumps. These patch pumps are especially beneficial for type 1 and insulin-dependent type 2 diabetes patients as they enhance quality of life with features like ease of use, discrete design, and real-time glucose monitoring capabilities. The need for these devices is driven by the growing prevalence of diabetes globally, increasing demand for self-managed diabetes care, and heightened patient awareness about advanced treatment options. Applications predominantly focus on continuous insulin delivery and glucose monitoring, beneficial for both pediatric and adult diabetic populations. The end-use scope spans hospitals, clinics, and home settings, reflecting the versatility and broad adoption potential of these devices.

Key growth factors include technological advancements, integration of artificial intelligence in diabetes management, and a supportive regulatory landscape. Opportunities exist in expanding product availability in emerging markets and enhancing connectivity features for real-time monitoring and feedback. Companies can capitalize on these trends through strategic partnerships, investment in R&D, and strengthening distribution networks. However, market growth faces challenges including high costs of devices, reimbursement issues, and the need for rigorous training for effective use. Moreover, there is competition from traditional insulin delivery methods and apprehension among patients about adopting new technologies. Innovations such as closed-loop systems, predictive algorithms for insulin dosing, and improved biowearable sensors present areas ripe for exploration. The market is characterized by rapid technological changes and a competitive environment, necessitating agility and robust innovation pipelines for sustained business success. Companies should prioritize user-friendly designs, affordability, and enhanced patient engagement strategies to navigate these market dynamics effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Insulin Patch Pumps Market

The Insulin Patch Pumps Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising incidence and prevalence of diabetes
  • Need for ease in the delivery of insulin
  • Increasing assistance from various governments
• Market Restraints
  • Rise in insulin cost with unfavorable insurance policies
• Market Opportunities
  • Advancement in diabetes management devices
  • Growing investment to develop technically advanced patch pumps
  • Use of artificial intelligence and availability of custom-made patch pumps
• Market Challenges
  • Less user friendliness due to complexity of the device

Porter's Five Forces: A Strategic Tool for Navigating the Insulin Patch Pumps Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Insulin Patch Pumps Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Insulin Patch Pumps Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Insulin Patch Pumps Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Insulin Patch Pumps Market

A detailed market share analysis in the Insulin Patch Pumps Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Insulin Patch Pumps Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Insulin Patch Pumps Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Insulin Patch Pumps Market

A strategic analysis of the Insulin Patch Pumps Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Insulin Patch Pumps Market, highlighting leading vendors and their innovative profiles. These include A. Menarini Industrie Farmaceutiche Riunite S.r.l., Abbott Laboratories, Becton, Dickinson and Company, CeQur SA, Debiotech S.A., EOFlow Co., Ltd., F. Hoffmann-La Roche Ltd., Insulet Corporation, Kaleido by ViCentra B.V., London Diabetes Centre, Sanofi S.A., Sigi by AMF Medical, Tandem Diabetes Care, Inc., Terumo Group, and Ypsomed AG.

Market Segmentation & Coverage

This research report categorizes the Insulin Patch Pumps Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Mode, market is studied across Basal and Bolus.
• Based on Product, market is studied across Disposable and Reusable.
• Based on Disease Indication, market is studied across Type 1 Diabetes and Type 2 Diabetes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidence and prevalence of diabetes
    • 5.1.1.2. Need for ease in the delivery of insulin
    • 5.1.1.3. Increasing assistance from various governments
  • 5.1.2. Restraints
    • 5.1.2.1. Rise in insulin cost with unfavorable insurance policies
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancement in diabetes management devices
    • 5.1.3.2. Growing investment to develop technically advanced patch pumps
    • 5.1.3.3. Use of artificial intelligence and availability of custom-made patch pumps
  • 5.1.4. Challenges
    • 5.1.4.1. Less user friendliness due to complexity of the device
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Insulin Patch Pumps Market, by Mode

• 6.1. Introduction
• 6.2. Basal
• 6.3. Bolus

7. Insulin Patch Pumps Market, by Product

• 7.1. Introduction
• 7.2. Disposable
• 7.3. Reusable

8. Insulin Patch Pumps Market, by Disease Indication

• 8.1. Introduction
• 8.2. Type 1 Diabetes
• 8.3. Type 2 Diabetes

9. Americas Insulin Patch Pumps Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Insulin Patch Pumps Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Insulin Patch Pumps Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. A. Menarini Industrie Farmaceutiche Riunite S.r.l.
• 2. Abbott Laboratories
• 3. Becton, Dickinson and Company
• 4. CeQur SA
• 5. Debiotech S.A.
• 6. EOFlow Co., Ltd.
• 7. F. Hoffmann-La Roche Ltd.
• 8. Insulet Corporation
• 9. Kaleido by ViCentra B.V.
• 10. London Diabetes Centre
• 11. Sanofi S.A.
• 12. Sigi by AMF Medical
• 13. Tandem Diabetes Care, Inc.
• 14. Terumo Group
• 15. Ypsomed AG